Related Experiment Videos
Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor.
1Natl Institute for Physiological Sciences, Okazaki, Japan.
Neurochemical Research
|August 25, 2001
Summary
Mutations in the proteolipid protein (PLP) gene disrupt oligodendrocyte survival. This study reveals that mutant PLP proteins fail to secrete a crucial survival factor, likely due to incorrect folding.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutations in the proteolipid protein (PLP) gene are linked to oligodendrocyte degeneration.
- Wild-type PLP facilitates oligodendrocyte differentiation and survival via a C-terminal secreted factor.
- Intracellular trafficking defects are implicated in PLP mutation-related pathology.
Purpose of the Study:
- To investigate how naturally occurring PLP gene mutations (jimpy, jimpy msd, rumpshaker) impact the secretion of the oligodendrocyte survival factor.
- To determine if impaired secretion is due to protein misfolding or trafficking defects.
Main Methods:
- Development of a transient retroviral expression system for producing and transducing mutant PLP/DM20 cDNAs in NIH3T3 cells.
- Analysis of the secretion of PLP-related factors from NIH3T3 cells expressing wild-type and mutant PLP/DM20.
Main Results:
- NIH3T3 cells expressing mutant PLP/DM20s did not secrete the oligodendrocyte survival-promoting factor.
- The rumpshaker DM20 mutant, despite cell surface transport, exhibits incorrect folding.
Conclusions:
- Absence of the PLP-related survival factor secretion in cells with PLP mutations is primarily attributed to incorrect protein folding.
- Incorrect protein folding, rather than solely trafficking defects, is a key mechanism underlying PLP mutation-associated oligodendrocyte degeneration.